Moldovan president, Russian envoy to hash over bilateral ties and breakaway TransnistriaRussian Politics & Diplomacy July 25, 14:43
US will either have to put up with North Korea’s nuclear weapons or use force — expertWorld July 25, 14:33
Kremlin refrains from comments on media allegations about Tillerson’s possible resignationRussian Politics & Diplomacy July 25, 14:03
Kremlin comments on US potentially funneling weapons to KievRussian Politics & Diplomacy July 25, 13:45
Kremlin says Russia, US not negotiating renewal of adoptionsRussian Politics & Diplomacy July 25, 13:37
Russian Ice Hockey Federation to render assistance to banned forward ZaripovSport July 25, 13:27
Press review: Malorossiya as an EU taboo and Moldova’s animosity to Russian peacekeepersPress Review July 25, 13:00
Poll reveals most Russians familiar with Jehovah’s Witnesses support its banSociety & Culture July 25, 12:11
Lithuania keeps tipping off NATO allies on Russian-Chinese naval drills in Baltic SeaMilitary & Defense July 25, 12:02
MOSCOW, October 29. /TASS/. The Federal Antimonopoly Service (FAS) wants to introduce a simplified procedure for admission of medicines, previously registered in the US and Europe to Russia, the head of FAS Igor Artemyev said on Thursday speaking at a cabinet session.
"It is necessary to check the history [of these medicines]. This system should not be automatic, we have to check, but if it was registered in the United States or Europe, there must be a simplified procedure for the introduction of these medicines in the Russian Federation," he said.
Artemyev also said that in the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program.
"It is necessary to add an aspect about the sale of medicines via retail chains there. I would say that the issue of substitution should be solved not by 2018 but by 2017. This will have a significant effect on prices and improve competition in healthcare sector," he said.